Transplantation Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Transplantation stocks.

Transplantation Stocks Recent News

Date Stock Title
Nov 23 TMDX 2 Hypergrowth Stocks That Are Screaming Buys in November
Nov 22 JAZZ ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run?
Nov 22 JAZZ Jazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler
Nov 22 TMDX Jim Cramer on TransMedics Group, Inc. (TMDX): ‘I Don’t Know How You Can Really Make A Lot Of Money In That Business, Frankly’
Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
Nov 20 TMDX Jim Cramer Likes Devon Energy, But Calls Another Stock 'Far Superior'
Nov 19 TMDX TransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nov 19 JAZZ Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference
Nov 19 TMDX TransMedics: Long-Term Thesis Hasn't Changed At All
Nov 19 JAZZ Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?
Nov 19 JAZZ Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment
Nov 18 TMDX Navigating 11 Analyst Ratings For TransMedics Gr
Nov 18 JAZZ Jazz Pharmaceuticals: High Uncertainty, Low Risk
Nov 18 JAZZ Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now?
Transplantation

Browse All Tags